Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited

BACKGROUND: Intravenous recombinant tissue plasminogen activator (rtPA) is approved in Europe for use in patients with acute ischaemic stroke who meet strictly defined criteria. IST-3 sought to improve the external validity and precision of the estimates of the overall treatment effects (efficacy an...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Sandercock, Peter, Lindley, Richard, Wardlaw, Joanna, Dennis, Martin, Innes, Karen, Cohen, Geoff, Whiteley, Will, Perry, David, Soosay, Vera, Buchanan, David, Venables, Graham, Czlonkowska, Anna, Kobayashi, Adam, Berge, Eivind, Slot, Karsten Bruins, Murray, Veronica, Peeters, Andre, Hankey, Graeme J, Matz, Karl, Brainin, Michael, Ricci, Stefano, Cantisani, Teresa A, Gubitz, Gordon, Phillips, Stephen J, Antonio, Arauz, Correia, Manuel, Lyrer, Phillippe, Kane, Ingrid, Lundstrom, Erik
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2011
Предметы:
Update
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286387/
https://ncbi.nlm.nih.gov/pubmed/22129158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-12-252
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы